OB-001(Oisin Biotechnologies)

N/A

Report date: 2023/05/17 08:51:46

Base Information

Drug NameOB-001(Oisin Biotechnologies)
Drug Alias NameOB-001
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceCaspase-9 activators
TargetsCaspase-9
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVoisin Consulting Inc
China Registration ClassN/A

Develop Information

Active CompaniesVoisin Consulting Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A